158 related articles for article (PubMed ID: 31372869)
1. Facility Type is Another Factor in the Volume-Outcome Relationship for Complex Hepatopancreatobiliary Procedures.
Wilson GC; Geller DA
Ann Surg Oncol; 2019 Nov; 26(12):3811-3812. PubMed ID: 31372869
[No Abstract] [Full Text] [Related]
2. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM
J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111
[TBL] [Abstract][Full Text] [Related]
3. Hospital Surgical Volume and 3-Year Mortality in Severe Prognosis Cancers: A Population-Based Study Using Cancer Registry Data.
Taniyama Y; Tabuchi T; Ohno Y; Morishima T; Okawa S; Koyama S; Miyashiro I
J Epidemiol; 2021 Jan; 31(1):52-58. PubMed ID: 31932528
[TBL] [Abstract][Full Text] [Related]
4. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.
Elshami M; Ahmed FA; Hue JJ; Kakish H; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2023 Feb; 173(2):289-298. PubMed ID: 36402613
[TBL] [Abstract][Full Text] [Related]
5. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
Wu LM; Zhang LL; Chen XH; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
7. Problems in staging of pancreatic and hepatobiliary tumours.
Schmied BM; Z'graggen K; Redaelli CA; Büchler MW
Ann Oncol; 2000; 11 Suppl 3():161-4. PubMed ID: 11079134
[No Abstract] [Full Text] [Related]
8. Management of primary hepatopancreatobiliary small cell carcinoma.
Groeschl RT; Christians KK; Turaga KK; Gamblin TC
J Surg Oncol; 2013 Jun; 107(7):692-5. PubMed ID: 23280574
[TBL] [Abstract][Full Text] [Related]
9. Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies.
McNamara MG
Curr Probl Cancer; 2018; 42(1):8-11. PubMed ID: 29397186
[No Abstract] [Full Text] [Related]
10. Systematic review and meta-analysis on volume-outcome relationship of abdominal surgical procedures in Germany.
Hendricks A; Diers J; Baum P; Weibel S; Kastner C; Müller S; Lock JF; Köhler F; Meybohm P; Kranke P; Germer CT; Wiegering A
Int J Surg; 2021 Feb; 86():24-31. PubMed ID: 33429078
[TBL] [Abstract][Full Text] [Related]
11. Effects of surgical volumes on the survival of endometrial carcinoma.
Becker JH; Ezendam NP; Boll D; van der Aa M; Pijnenborg JM
Gynecol Oncol; 2015 Nov; 139(2):306-11. PubMed ID: 26348315
[No Abstract] [Full Text] [Related]
12. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
[TBL] [Abstract][Full Text] [Related]
13. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
[TBL] [Abstract][Full Text] [Related]
14. [Liver, Pancreas, Biliary Tract Cancer Current Issues of Surgical Margin, R0 and R1, in Surgical Resection for Hepatobiliary Pancreatic Cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2018 Oct; 45(10):1415-1416. PubMed ID: 30382035
[No Abstract] [Full Text] [Related]
15. Survival of Danish cancer patients 1943-1987. Digestive organs.
Johansen C; Soll-Johanning H; Kolstad H; Lynge E; Carstensen B
APMIS Suppl; 1993; 33():35-76. PubMed ID: 8512741
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Zentralbl Chir; 2016 Feb; 141(1):6. PubMed ID: 27336076
[No Abstract] [Full Text] [Related]
17. [Liver, Pancreas, Biliary Tract New Therapeutic Strategies for Advanced Pancreatic Cancer].
Miyazaki M
Gan To Kagaku Ryoho; 2017 Oct; 44(10):835-836. PubMed ID: 29066675
[No Abstract] [Full Text] [Related]
18. Digestive organs.
Holm LE; Rosén M; Ericsson J; Stenbeck M; Barlow L
Acta Oncol; 1995; 34 Suppl 4():11-37. PubMed ID: 7873209
[No Abstract] [Full Text] [Related]
19. [The role of hemosorption in the combination therapy of biliary, pancreatic and duodenal tumors].
Ender LA; Agureev AI; Lobakov AI; Lechtman AM
Vopr Onkol; 1982; 28(9):104-8. PubMed ID: 6750913
[No Abstract] [Full Text] [Related]
20. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group.
Faivre J; Forman D; Estève J; Obradovic M; Sant M
Eur J Cancer; 1998 Dec; 34(14 Spec No):2184-90. PubMed ID: 10070285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
